Cargando…
A Convenient Truth: Cost of Medications Need Not Be a Barrier to Hepatitis B Treatment
Drugs that are inexpensive to manufacture and simple to administer greatly expand the potential to help tens of millions of people who need treatment for chronic hepatitis B virus (HBV) infection. Key program implementation challenges include identifying who would benefit from antiviral medication a...
Autor principal: | Barnhart, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Global Health: Science and Practice
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982244/ https://www.ncbi.nlm.nih.gov/pubmed/27353613 http://dx.doi.org/10.9745/GHSP-D-16-00128 |
Ejemplares similares
-
The Inconvenient Truth About Convenience and Purposive Samples
por: Andrade, Chittaranjan
Publicado: (2020) -
The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?
por: Jeng, Wen-Juei, et al.
Publicado: (2023) -
A Convenience
Publicado: (1883) -
Overly convenient falsehoods and inconvenient truths: Not what leaders thought they would learn()
por: Adler, Nancy J.
Publicado: (2022) -
Public Health’s Inconvenient Truth: The Need to Create Partnerships With the Business Sector
por: Majestic, Elizabeth
Publicado: (2009)